• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Pheton Holdings Ltd

    9/9/24 4:30:22 PM ET
    $PTHL
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $PTHL alert in real time by email
    6-K 1 ea0213842-6k_pheton.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of September 2024

     

    Commission File Number: 001-42263

     

    Pheton Holdings Ltd

     

    Room 306, NET Building,

    Hong Jun Ying South Road, Chaoyang District,

    Beijing, China

    (Address of principal executive office)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

     

    Form 20-F ☒ Form 40-F ☐

     

     

     

     

     

    Pricing and Closing of Initial Public Offering

     

    On September 6, 2024, Pheton Holdings Ltd (the “Company”) closed its initial public offering (“IPO”) of 2,250,000 Class A ordinary shares, par value $0.0001 per share (the “Ordinary Shares”). The Company completed the IPO pursuant to its registration statement on Form F-1 (File No. 333-274944), which was initially filed with the U.S. Securities and Exchange Commission (the “SEC”) on October 11, 2023, as amended, and declared effective by the SEC on March 29, 2024 and on September 4, 2024. The Ordinary Shares were priced at $4.00 per share, and the offering was conducted on a firm commitment basis. The Ordinary Shares were previously approved for listing on The Nasdaq Capital Market and commenced trading under the ticker symbol “PTHL” on September 5, 2024.

     

    In connection with the IPO, the Company issued a press release on September 5, 2024, announcing the pricing of the IPO, and a press release on September 6, 2024, announcing the closing of the IPO, respectively. Copies of these press releases are attached hereto as Exhibit 99.1 and Exhibit 99.2, respectively, and are incorporated by reference herein.

     

    This report does not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

     

    1

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      Pheton Holdings Ltd
         
    Date: September 9, 2024 By:

    /s/ Jianfei Zhang

      Name:  Jianfei Zhang
      Title:

    Chief Executive Officer and

    Chairman of the Board of Directors

     

    2

     

     

    EXHIBIT INDEX

     

    Exhibit No.   Description
    99.1   Press Release on Pricing of the Company’s Initial Public Offering
    99.2   Press Release on Closing of the Company’s Initial Public Offering

     

     

    3

     

    Get the next $PTHL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PTHL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $PTHL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Pheton Holdings Ltd Announces Closing of Initial Public Offering

      BEIJING, China, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the "Company" or "Pheton"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today announced the closing of its initial public offering (the "Offering") of 2,250,000 Class A ordinary shares at a public offering price of $4.00 per share, for total gross proceeds of $9 million, before deducting underwriting discounts and other related expenses. The Company has granted the underwriters an option, exercisable within 45 days from the closing date of the Offering, to purchase up to an additional 337,500 Class A ordinary shares at the initi

      9/6/24 4:08:31 PM ET
      $PTHL
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $PTHL
    SEC Filings

    See more
    • SEC Form SCHEDULE 13G filed by Pheton Holdings Ltd

      SCHEDULE 13G - Pheton Holdings Ltd (0001970544) (Subject)

      5/5/25 11:05:21 AM ET
      $PTHL
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form S-8 filed by Pheton Holdings Ltd

      S-8 - Pheton Holdings Ltd (0001970544) (Filer)

      4/22/25 4:15:41 PM ET
      $PTHL
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 20-F filed by Pheton Holdings Ltd

      20-F - Pheton Holdings Ltd (0001970544) (Filer)

      3/20/25 4:30:31 PM ET
      $PTHL
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care